Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Hypertension Congress 2020

About Hypertension-2020

Conference Series is delighted to host the 4thInternational Conference on Hypertension & Cardiac Health (Hypertension Congress 2020) during March 25-26, 2020 at Tokyo, japanHypertension Congress 2020, is open to all the healthcare professional with an interest in Hypertension and Cardiovascular research & allied fields.

Hypertension 2020 Meeting is based on the theme “Exploring the new horizons to cure Hypertension & Cardiac diseases”.

This Hypertension Congress is not only provides a great platform to exchange ideas, discuss case studies, share research outputs in the area of Hypertension & Cardiac care, but also provide an opportunity to meet the experts across the globe and network. Hypertension 2020 will mark the presence of international and national leaders in the sector of Cardiovascular Research, leading clinicians working in Clinical trial projects, Physicians, Primary Healthcare Providers, Academic researchers, Business Delegates, Government officials and key decision makers.

The aim of this Hypertension meeting is to discuss the strategies for screening, prevention and treatment of High blood pressure and related cardiac events. This Hypertension Congress, Japan, includes several Plenary presentations, interactive sessions, Video presentations, Poster Presentations, Special case studies sessions, Young Research Forums, Networking sessions etc. The sessions in this Hypertension Conference will help the young investigators including healthcare practitioners, Primary healthcare providers, Academic investigators to acquire in depth knowledge from the basic study of Hypertension and Cardiac health to Clinical aspects of Hypertension and Cardiac Health management.
 

Who Should Attend?

Hypertension Congress 2020 welcomes the submissions and call to the experts working in the areas of Hypertension Research, Cardiac Research, Clinical studies in Cardiovascular Diseases, Vendors, & suppliers in the segment of Cardiology & cardio vascular products etc. We expect the foot prints of Directors, Deans, Laboratory heads, Cardiologists, Clinical Directors, Physicians, Primary Healthcare Providers, representatives of associates, Hospital & healthcare providers, representatives from Pharma & Biopharma companies associated in the allied fields:

  • Hypertension & Heart Failure
  • Cardiology & Cardiovascular disorders
  • Atherosclerosis & Cardio Metabolic Syndrome
  • Clinical Trials & Clinical data management companies
  • Endocrinology, Diabetes & Nephrologists
  • Diagnostics providers
  • Family Medicine & Critical care
  • Cardiology & Stroke
  • Dyslipidemia
  • Gynecologists
  • Hypertension
  • Imaging & Disgnosis
  • Internal Medicine
  • Nutrition & Obesity
  • Vascular disease & vascular biology
  • Nursing & critical care
  • Related Societies & Associations
  • Academic publishers

Why attend?

  • Hypertension 2020 provides the opportunity to connect cross-disciplinary researchers and experts from all-round the globe.
  • Interactive sessions will help the young investigators to interact with experts
  • Networking opportunities during sessions of Hypertension 2020 to promote collaborative research
  • Multiple awards at Hypertension 2020 Congress: Best Research paper Awards, Young Researcher Awards, Best poster Award etc.
  • Vendors/ solutions providers will have the opportunity to interact with end users and decision makers
  • Upgrade your knowledge with new innovations and upcoming treatment strategies for Hypertension and Cardiac Health.

Session/ Tracks

  • Hypertension
  • Pulmonary Hypertension
  • Pediatric hypertension
  • Hypertension and Cardiac Arrest
  • Gestational Hypertension
  • Hypertension and Obesity
  • Hypertension – Stress and Stroke
  • Hypertension and Diabetes
  • Diet and Exercise for Hypertension
  • Hypertension treatment
  • Advanced Treatments Approaches
  • Clinical case reports in Hypertension & Cardiology
  • Causative Factors and Risk Assessment

 

Market analysis

As per a statement of World Health Organization (WHO), Hypertension is one of the silent killers in 21st century and is one of the biggest global public health concerns. Hypertension is major contributors of cardiac complications, stroke, heart diseases, kidney failure, blindness, including premature death and disabilities. Hypertension is curable as well as treatable for which there is a need of involvement from individual entities, government and private sectors, health workers, civil societies and moreover individual awareness is highly recommended.

As per the estimation of WHO, globally more than 1.13 billion of people are affected with Hypertension among which less than 1 in each 5 is under control. Unhealthy diets, lack of physical activities, consumption of alcohol & tobacco are the main contributing factors of Hypertension. To reduce the prevalence by 25% by 2025, WHO along with United States Center for Disease Control and Prevention launched Global heart Initiative in 2016. 
 
Globally, Hypertension or high Blood Pressure leads to 7.5million death cases which shares about 12.8% of all death cases recorded. Hypertension is also accounts about 57million disabilities adjusted life years which is about 3.7% of total adjusted life years. Hypertension is the primary risk factor of coronary heart disease, ischemic & haemorrhagic stroke. 
 
Global prevalence of Hypertension in adult aged>25 was about 40% in 2008. Between 1980 to 2008 the prevalence was moderate. But, due to sharp growth in population, ageing population the uncontrolled Hypertension reached to 1 billion 2008 from 600 million. The prevalence of Hypertension was highest in Africa (>40%) and lower in Americas (35%).
 
As per the research of some independent firm, global Hypertension drug market is estimated to be $24.7billion in 2018 & expected to hit about $19.3 billion by 2029 with an annual CAGR of -2.3% in between 2019 to 2029. Main Drugs in the Hypertension market are Tacleer, Uptravi, Opsumit, Letairis, Adcirca, Revatio, Adempas, Veletri, Oremitram, Tyvaso, Remodulin. Major classes of drugs used are: Calcium Channel Blockers, Diuretics, Beta Blockers Vasodilators, Angiotensin Converting Enzyme Inhibitors, Alpha Blockers, Angiotensin Receptor Blockers, and Renin Inhibitors. Major players in the anti-hypertensive drugs market are: Actelion, AstraZeneca, Boehringer Ingelheim, Daiichi Sankyo, Johnson & Johnson, Merck & Co., Novartis, Pfizer, Sanofi Aventis and United Therapeutics. 
 
As per another survey, global Pulmonary Arterial Hypertension (PAH) market is forecasted to touch $9.3billion by 2026 with an CAGR of 5.6% during 2019-2026. Rising cases of PAH and the support from federal Government and private organizations, development of Orphan Drug products for PAH is fuelling the growth of the market. 
 

To Collaborate Scientific Professionals around the World

Conference Date March 25-26, 2020

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Supported By

Journal of Hypertension International Journal of Cardiovascular Research Journal of Clinical & Experimental Cardiology

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner